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Available online 11 November 2016Objectives: Since the metabolism of the organochlorine pesticide dichlorodiphenyltrichloroethane (DDT) is not
fully known in humans, we evaluated if circulating levels of a major breakdown product of DDT, p,p′-DDE,
were related to genome-wide genetic and methylation variation in a population-based sample.
Methods: In the population-based Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study
(1016 subjects all aged 70), circulating levels of p,p′-DDE were analyzed by high-resolution chromatography
coupled to high-resolution mass spectrometry (HRGC/HRMS). Genetic variants were genotyped and imputed
(1000 Genomes reference, March 2012 release). Methylation sites were assayed using the Illumina
HumanMethylation450 array in whole blood. A genome-wide association study (GWAS) approach was applied.
Results: Evidence for genome-wide signiﬁcant association with p,p′-DDE levels was observed only for a locus at
chromosome 19 corresponding to the CYP2B6 gene (lead SNP rs7260538). Subjects being homozygote for the
G allele showed a median level of 472 ng/g lipid, while the corresponding level for those being homozygote
for the T allele was 192 ng/g lipid (p=1.5 × 10−31). An analysis conditioned on the lead SNP disclosed a distinct
signal in the same gene (rs7255374, position chr19:41520351; p= 2.2 × 10−8).
A whole-genome methylation analysis showed one signiﬁcant relationship vs. p,p′-DDE levels (p= 6.2 × 10−9)
located 7 kbdownstream the CYP2B6 gene (cg27089200, position chr19:41531976). This CpG-sitewas also relat-
ed to the lead SNP (p= 3.8 × 10−35), but mediated only 4% of the effect of the lead SNP on p,p′-DDE levels.
Conclusion: Circulating levels of p,p′-DDE were related to genetic variation in the CYP2B6 gene in the general el-
derly population. DNA methylation in this gene is not closely linked to the p,p′-DDE levels.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
GWAS
CYP2B6
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Methylation1. Introduction
Dichlorodiphenyltrichloroethane (DDT) is an insecticide heavily
used since the second half of World War II. Due to reproductive prob-
lems observed in wild animals, DDT was banned in the 1970s and
1980s in most high-income countries. Despite its toxic properties, DDTl Sciences, Occupational and
sala, Sweden.
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.uu.se (P.M. Lind).
. This is an open access article underis still used in many developing countries, mainly to ﬁght malaria
(Eskenazi et al., 2009). A major metabolite of DDT is 2, 2-bis (4-
chlorophenyl)-1, 1-dichloroethene (p,p′-DDE). p,p′-DDE is highly lipo-
philic and thereby accumulates in adipose tissue and has been estimat-
ed to have a half-life of 10–15 years. Although DDT is not used as a
pesticide any longer in high-income countries, due to its persistence
in the environment and accumulation in the food chain in ﬁsh and
meat, there is still exposure taking place. However, this exposure is
not as high as before the ban. An accumulation occurs with ageing, so
higher levels of DDT/p,p′-DDE are seen in older subjects than in younger
individuals as a result from a continuous cumulative exposure (Ye et al.,
2015). We have recently reported that high levels of p,p′-DDE are relat-
ed to prevalent obesity, diabetes andhypertension (Lee et al., 2011; Lind
et al., 2014b; Ronn et al., 2011).the CC BY license (http://creativecommons.org/licenses/by/4.0/).
213L. Lind et al. / Environment International 98 (2017) 212–218Several studies have shown that DDT alters the activity of manymi-
crosomal enzymes, including those involved in phase I and phase II me-
tabolism of xenobiotics (Lubet et al., 1992; Madhukar and Matsumura,
1979) in different species (Abernathy et al., 1971; Bunyan et al., 1972;
Henneman et al., 1994; Li et al., 1995; Lubet et al., 1990). Pharmacody-
namic studies on CYP2B induction indicated no important differences
between the isomer p,p′-DDT and its metabolite DDE (Nims et al.,
1998). The effects consisted mainly of an induction of the CYP2B sub-
family, a lesser induction on CYP3A, and minimal or no induction of
CYP1A. On this basis, DDT has been considered a phenobarbiturate-
type of inducer (Nims et al., 1998; Okey, 1972).
Toxicokinetic studies of persistent organic pollutants, such as DDT/
DDE, have mainly been conducted in an experimental setting (as cited
above), and therefore such results have to be validated in humans.
One way to perform such studies in humans is to relate functional ge-
netic variations in genes known to be involved in the kinetics of envi-
ronmental contaminants to levels of the contaminant of interest, like
relating levels of polychlorinated biphenyls to single nuclear polymor-
phisms (SNP) in the CYP1A1 gene (Lind et al., 2014a). However, such
an approach demands a detailed prior knowledge of the metabolism
of the compound of interest. Another approach is to use a genome-
wide association study (GWAS), which test a great number of SNP
across the genome without a prior hypothesis. We have previously
used the GWAS approach and found that circulating levels of several
of the PCBs were related to variation in the CYP2B6 gene (Ng et al.,
2015b), and whole blood manganese levels to be related to variation
in the SLC39A8 and SLC30A10 genes, while mercury and cadmium
levels shared associations with variation in other genes (Ng et al.,
2015a).
The expression of a protein is not only governed by the variation in
base-pairs in the genes, but also by epigeneticmechanisms, likemethyl-
ation. For example, it has been shown that p,p′-DDE levels are linked to
alterations in global DNA methylation (Rusiecki et al., 2008).
Since the metabolism of DDT and p,p′-DDE has mainly been stud-
ied in the experimental setting, we used the GWAS approach to relate
genetic variation to circulating levels of p,p′-DDE. For this purpose, we
used data from the Prospective Investigation of the Vasculature in
Uppsala Seniors (PIVUS) study (Lind et al., 2005), in which extensive
genotyping has been performed, together with measurements of cir-
culating p,p′-DDE levels. We also investigated if p,p′-DDE levels
were related to differential methylation using a whole-genome
approach.2. Material and methods
2.1. Subjects
The PIVUS study was originally designed to study markers of sub-
clinical cardiovascular disease as risk factors for incident cardiovascular
diseases (Lind et al., 2005). Eligible subjectswere all aged 70 and lived in
the community of Uppsala, Sweden, with a total population of approxi-
mately 175,000 individuals. The subjects were randomly chosen from
the register of community living kept by the City council of Uppsala.
Of a total of 2027 invited individuals (50% being females), 1016 subjects
participated, giving a participation rate of 50.1%. The study was ap-
proved by the Ethics Committee of the University of Uppsala and all
the participants gave their informed consent prior to the study.
All subjects were investigated in themorning after an overnight fast.
Nomedication or smokingwas allowed aftermidnight. The participants
were asked to answer a questionnaire about their medical history,
smoking habits and regular medication. Blood samples for determina-
tions of p,p′-DDE levels, genotyping and DNA methylation were drawn
at the same time in the fasting state at the age of 70 years. p,p′-DDE
levels weremeasured in serum and DNAwas prepared from leukocytes
in whole blood specimens.2.1. p,p′-DDE analyses
p,p′-DDE levels were measured in stored serum samples using a
Micromass Autospec Ultima (Waters, Milford, MA, USA) high-resolu-
tion gas chromatography coupled to a high resolution mass spectrome-
try (HRGC/HRMS) system based on the method by Sandau and
colleagues (Barr et al., 2003) with some modiﬁcations. A more detailed
description of the analysis in this sample has previously been presented
(Salihovic et al., 2012).
2.2. Genotyping and imputation
Genotyping was performed on all participants using the Illumina
Metabochip together with the Illumina OmniExpress chip. Samples
were excluded based on call rate b95%, extreme heterozygosity (N3
SD from themean), gender discordance, duplicated samples, close rela-
tives or ethnic outliers. Variants with exact Hardy-Weinberg equilibri-
um (HWE) p-value b 1 × 10−6, call rate b 0.99, SNPs with minor allele
frequency [MAF] b5% were excluded from the scaffold prior to imputa-
tion. The cleaned genotype datawere imputed up to the 1000Genomes,
March 2012 release reference panel (multi-ethnic panel on NCBI build
37 [b37]) using IMPUTE v.2.2.2.
2.3. Regional DNA methylation
Methylation sites across the genome were assayed using the
Illumina HumanMethylation450k Beadchip, which detects methylation
based on genotyping of bisulﬁte-converted genomic DNA, covering
482,421 CpG-sites and 3091 non-CpG sites. Samples were excluded
based on call rate (98.5% probes with detection p-value b 0.01), leuko-
cyte count N 10 (×109 cells/L), bisulﬁte conversion efﬁciency outliers,
or more than onemismatchwhen comparing the SNPs on the methyla-
tion chip and theOmni/Metabochip genotyping chips. Data on the X and
Y chromosomeswere not used in the analysis. A quantile normalization
of the signal intensities was performed per individual and undertaken
separately for type-I and type-II probes of the chip. Beta-values were
then calculated as the percentage methylation at a site, denoted degree
of methylation in the text. A total of 20,522 methylation sites were ex-
cluded from the analysis since their probes mapped to multiple loca-
tions in the genome with at least two mismatches, in accordance with
methods used by other investigators (Grundberg et al., 2013).
2.4. Statistical analyses
Since not normally distributed, p,p′-DDE was natural log-trans-
formed before analysis, and used in the further analysis as a continuous
variable. Since no priori hypotheses regarding which genes that could
be related to p,p′-DDE levels were given in the present study, a GWAS
with p,p′-DDE as dependent variable was performed using the score-
based test in SNPTEST 2.4.1 (Marchini et al., 2007), accounting for impu-
tation uncertainty in amissing data likelihood and assuming an additive
genetic effect. Only SNPs with MAF N0.05 and IMPUTE2 info N0.4 were
included in the analysis. Gender and two principal components (based
on the genetic structure in the sample, here used to adjust for any genet-
ic heterogeneity within the sample) were included as covariates and a
p-value b × 10−8 deﬁned a genome-wide signiﬁcant ﬁnding.
The genomic inﬂation factor lambda (Devlin and Roeder, 1999) was
calculated as a quality control to assess the evidence for residual popu-
lation structure that was not accounted for in the association analysis.
Even studies with relatively homogeneous populations are susceptible
to residual confounding by population stratiﬁcation.
The associations between SNPswithin and around CYP2B6 (10 kb up
and downstream of the transcript boundaries on b37 obtained by the
UCSC Table Browser [http://genome.ucsc.edu/cgi-bin/hgTables]) were
visualized using the program LocusZoom 1.1 (Pruim et al., 2010). Fol-
lowing identiﬁcation of the most signiﬁcantly associated SNP in the
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this lead SNP with an additive genetic effect in the regression model)
to identify additional distinct signals within or around CYP2B6. The
“beta” referred to in the following text and tables is the regression coef-
ﬁcient in linear regression analysis. Thus, a beta for a SNP as an indepen-
dent variable is the contribution of an additional allele.
Linear regression was used to analyze the relationships between the
degree of methylation at sites across the genome and p,p′-DDE levels,
adjusting for gender, leukocyte cell fractions according to Houseman
(Houseman et al., 2012) sample batch, bisulﬁte conversion efﬁciency,
storage time and smoking status (never, previous, current). Probes
with a SNP within 10 bp were ﬁltered out as were probes with known
genomic variants with a minor allele frequency of b1% according to
the HumanMethylation450 annotation ﬁles. A Bonferroni-adjustment
was used accounting for 322,756 tested methylation sites (critical p-
value 1.55 × 10−7). An interaction term (multiplicative) between the
lead methylation site and sex regarding p,p′-DDE levels were used to
evaluate any sex-differences in the lead methylation site vs. p,p′-DDE
levels relationship.
The GWAS and whole-genome methylation analysis were per-
formed as two separate analyses.
The relations between the 2046 SNPs within ±0.5 Mb (predictors)
and the lead methylation site were also analyzed by linear regression
analysis (p-value 2 × 10−5), including confounders stated above. In
studies using both SNPs and methylation it is possible test the causal
pathway: SNP- N methylation- N outcome to see if the association be-
tween a SNP and an outcome (like p,p′-DDE) is mediated by the meth-
ylation. Structural equation modeling (SEM) (Westland, 2015) was
used to evaluate the degree of mediation of the lead methylation site
on the relationship between the lead SNP and p,p′-DDE levels. Model
used: (lead SNP- N p,p′-DDE levels) (lead SNP- N lead methylation
site) (lead methylation site- N p,p′-DDE levels), where arrows indicate
linear regression.3. Results
Basic characteristics regarding diseases andmedications are given in
Table 1.Table 1
Self-reported history of cardiovascular (CV) disorders and regular drug intake
given in percentage in the investigated sample (n = 1016). CABG/
PCI = coronary revascularisation. N and percentage (in parenthesis) are given
for each variable. For p,p′-DDE, median and 25th and 75th percentiles are given
(in parenthesis).
Women 510 (50.2)
Myocardial infarction 72 (7.1)
Stroke 38 (3.7)
Angina pectoris 82 (8.1)
CABG/PCI 54 (5.3)
Congestive heart failure 39 (3.8)
Diabetes 88 (8.7)
Any regular drug 711 (70)
Any CV drug 457 (45)
Antihypertensive medication 325 (32)
Statins 152 (15)
Antidiabetic drugs 74 (7.3)
Aspirin/clopidogrel 182 (18)
Smoking 113 (11)
Obesity (BMI ≥ 30 kg/m2) 224 (22)
Education level: b9 years
10–12 years
N12 years
579 (57)
182 (18)
255 (25)
p,p′-DDE (ng/g lipid) 308 (170–570)3.1. p,p′-DDE levels and SNPs in the CYP2B6 gene
In the GWAS, we did not observe any evidence of systematic inﬂa-
tion of p-values reﬂecting residual population structure (Fig. 1, lower
panel; lambda, 1.01). Evidence for genome-wide signiﬁcant association
with p,p′-DDE levels was observed only for one locus at chromosome19
corresponding to the CYP2B6 gene (Fig. 1, upper panel).
A regional plot of the 769 SNPs within or close to CYP2B6 gene (chr
19, position range 41.4–41.6 Mb) is presented in Fig. 2. The lead SNP,
rs7260538 at position chr19:41514040, 19q13.2, is located in the intron
region of NM_000767.4 (minor allele frequency 0.44, Hardy-Weinberg
equilibrium 0.89, p= 1.5 × 10−31). As could be seen in Fig. 3, subjects
being homozygote for the G allele showed a median level of 472 ng/g
lipid, while the corresponding level for those being homozygote for
the T allele was 192 ng/g lipid (p = 1.5 × 10−31). Adjusting for BMI
did only alter this relationship to a very minor degree and the data
given above is without BMI-adjustment.
An analysis conditioned on the lead SNP disclosed a distinct signal
(rs7255374, position chr19:41,520,351) being associated with p,p′-
DDE (p=2.2 × 10−8; Supplementary Fig. 1, upper panel). This second-
ary signal is also located in the intron region of NM_000767.4. NoFig. 1.Manhattan plot for a genome wide association study (GWAS) for plasma p,p′-DDE
levels (upper panel) with −10log p-value at the y-axis and the gross position in the
genome at the x-axis. A Manhattan plot shows a point for each single nucleotide
polymorphism (SNP) that has been tested in a unique linear regression model vs. p,p′-
DDE levels. The red line indicates the GWAS level of signiﬁcance (p b 5 ∗ 10−8).
Fig. 2.Regional plot for linear regression analysis regarding associations between p,p′-DDE levels and single nucleotide polymorphisms (SNPs) in or close to the CYP2B6 gene. The -10log p-
values for the associations are given at the y-axis and thepositions at chromosome 19 are given at the x-axis. This ﬁgure is in fact only a zoom-in of the region of interest on chromosome 19
that is given in theManhattanplot in Fig. 1. The lead SNP is indicated by the greydiamond and the color of the other SNPs denotes the linkagedisequilibrium(r2) (meaning the relationship
between the different SNPs in the region) in relation to the top hit.
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of these signals (see Supplementary Fig. 1, lower panel). If both the lead
SNP and this secondary signal entered a regression model as indepen-
dent variables and p,p′-DDE as dependent variable, these two SNPs ex-
plained 17% of the variation in p,p′-DDE levels in PIVUS, as determined
from the R2-value given in the regression model (data not shown in
tables).
In Suppl. Table 1, all associations with p b 5 ∗ 10−8) are shown.
CYP2B6 has 28 known alleles (http://www.cypalleles.ki.se/cyp2b6.
htm). The most common of the haplotypes is CYP2B6*6 (frequency
0.038 in the present sample). This haplotype, deﬁned by two SNPs
(rs3745274, Chr19:41512841 and rs2279343, chr19:41515263), was
related to p,p′-DDE levels in our sample (p = 0.00046). However, in
an analysis conditioned on the two SNPs deﬁning the CYP2B6*6 haplo-
type, several of the other SNPs in the CYP2B6 region were still signiﬁ-
cantly related to p,p′-DDE levels (p b 10−10 for the most strongly
associated variant, Supplementary Fig. 2).Fig. 3. Box plot showing p,p′-DDE levels for the different genotypes of rs7260538 at
chromosome 19. Values N 2000 are not shown.3.2. p,p′-DDE levels and methylation in the CYP2B6 gene
A whole-genome methylation analysis suggested an association
between one loci at chromosome 19 and p,p′-DDE levels (beta 0.12,
SE 0.021, p = 6.2 ∗ 10−9, ﬁg. 4). According to that regression
model, a change in 400 ng/g lipids in p,p′-DDE (the interquartile
range) corresponds to a change in methylation at that loci by
0.0091. Adding BMI as a confounder to the model did only change
the result marginally.
In Suppl. Table 2, all associationwith a p-value b 10−5 are shown, in-
cluding regression coefﬁcients (beta) and SE.
This lead methylation site being located approximately 7 kb down-
stream the CYP2B6 gene (cg27089200, position chr19:41531976,
mean value 0.25 (SD 0.07)) was also related several SNPs in this region
(most signiﬁcant SNP in this analysis was rs7255904, beta 0.50, SE
0.020, p = 1.3 × 10−101). This methylation site was associated with
the lead SNP (rs7260538) (beta −0.32, SE 0.025, p = 3.8 × 10−35,
Suppl. Fig. 3).
When the relationship between the lead methylation site and p,p′-
DDE levels was conditioned on the lead SNP, the lead methylation site
was no longer signiﬁcant (p = 0.25). A mediation analysis (SEM)
showed that the lead methylation site only mediated 4% of the effect
of the lead SNP on p,p′-DDE levels.
We investigated if any of the drug classes given in Table 1 could con-
found the relationships between p,p′-DDE levels and the lead SNP or the
lead methylation site by including the 14 kinds of drugs in one regres-
sionmodel with the lead SNP and onemodel with the leadmethylation
site. However, adjustment for the 14 drugs did not substantially alter
the relationships between SNP/methylation sites and p,p′-DDE levels
described above.
When including an interaction term between p,p′-DDE levels (con-
tinuous) and sex in the regression model relating p,p′-DDE levels vs.
the lead methylation site, no signiﬁcant interaction was seen (p =
0.55). Therefore the regression coefﬁcient (beta) was similar in men
and women (0.15 in men and 0.11 in women).
The lower panel shows the corresponding Q-Q plot with the ob-
served p-values (on a −10log scale) from all the linear regression
models using all the available SNPs plotted vs. the expected p-values
Fig. 4.Manhattan plot for a whole-genomemethylation analysis of plasma p,p′-DDE levels in relation to ~450 kmethylation sites (upper panel)with−10log p-value at the y-axis and the
gross position in the genome at the x-axis. The lower panel shows a regional plot for linear regression analysis regarding associations between p,p′-DDE levels and methylation loci in or
close to the CYP2B6 gene. The -10log p-values for the associations are given at the y-axis and the positions at chromosome 19 are given at the x-axis. The lead methylation site in this
analysis showed a p-value of 6.2 ∗ 10−9.
216 L. Lind et al. / Environment International 98 (2017) 212–218(given from a simulation of N1 million regression models). The red line
denotes the line of identity.
4. Discussion
The present study showed that circulating levels of p,p′-DDE, a more
stable metabolite of DDT, were related to genetic variation in the
CYP2B6 gene. This ﬁnding is in accordance with experimental studies
showing that DDT and its metabolite p,p′-DDE cause induction of
CYP2B enzymes (Nims et al., 1998; Okey, 1972), but this is the ﬁrst
study to show this link between p,p′-DDE and CYP2B6 in humans. We
found DNA methylation in this gene to not play a major role for the
p,p′-DDE levels, since the impact of DNA methylation was minor when
taken the lead SNP into account in the SEM analyses.p,p′-DDE is still measurable in the circulation in almost all individ-
uals in high-income countries (Salihovic et al., 2012). The median con-
centration of p,p′-DDE in this study of elderly individuals is similar to
those previously reported from Sweden and Norway (Hagmar et al.,
2006; Hardell et al., 2010; Sandanger et al., 2006). However, the levels
of p,p′-DDE in the present study were about three times lower when
comparing with elderly individuals from Belgium (Koppen et al.,
2002) and the United States (NHANES 2003–2004) in samples collected
during the same time period.
The CYP2B6 expression and activity is highly variable between indi-
viduals, owing to genetic polymorphisms. Regarding CYP2B6, interindi-
vidual variability exist at both mRNA and protein levels, and these
differences are roughly over 100-fold (Wang and Tompkins, 2008). Sev-
eral functionally relevant single-nucleotide polymorphisms (SNPs)
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ly deﬁcient allele is CYP2B6*6. The CYP2B6*6 homozygous carriers
CYP2B6*6/*6, and its compound heterozygous genotypes CYP2B6*1/*6
were found to show poor metabolizer phenotypes for several drugs in
vivo (Lang et al., 2001). It can therefore be assumed that SNPs in this
gene could identify those with a poor metabolizing capacity of p,p′-
DDE as well.
From the conditional analysis it is evident that there are at least two
distinct association signals in the CYP2B6 region related to p,p′-DDE
levels. Since both of these SNPs are located in an intronic region, it is
far from clear how these SNP might inﬂuence the p,p′-DDE levels, but
together they explained 17% of the variation in p,p′-DDE levels in
PIVUS, showing that CYP2B6 activity is of importance for the circulating
levels of this organochlorine pesticide.
In contrast to the top hits in the CYP2B6 region described here, it is
known that the common CYP2B6*6 haplotype, encoding a change
from glutamine to histidine in one amino acid position of the protein,
could govern CYP2B6 activity in vitro. Also, the CYP2B6*6 haplotype
was related to the p,p′-DDE levels, but when a further analysis was con-
ducted conditioned on the SNPs in the CYP2B6*6 haplotype, a great
number of other SNPs in the region were also signiﬁcantly related to
p,p′-DDE levels, suggesting that there is additional genetic variation of
importance for p,p′-DDE levels in this region, beyond the known
CYP2B6*6 haplotype. It should be noted that the frequency of the
CYP2B6*6 haplotype was low, so the power to detect an independent
contribution of this haplotype is limited.
The CYP2B6 enzyme ismainly expressed in the liver and in the brain
in humans (Lamba et al., 2003) The expression of this enzyme in the
liver is very important, since it has been estimated that CYP2B6 metab-
olizes about 25% of all pharmaceutical drugs on the market, and the ex-
pression is subject to a high degree of variability due to variation in the
gene (Yang et al., 2013) Since DDT and p,p′-DDE are highly lipophilic
they do accumulate in liver tissue and previously experimental studies
and the present study show that variation in CYP2B6 is of major impor-
tance for the clearance of DDT/p,p′-DDE from the body in humans.
In addition to analyzing the relationships between p,p′-DDE levels
and genetic variation in the CYP2B6 gene, we also investigated how
p,p′-DDE levels were associated with the degree of methylation in
CpG-sites across the genome, since methylation could affect the activity
of the enzyme. We found that the degree of methylation in one locus,
7 kb downstream of the CYP2B6 gene was related to p,p′-DDE levels.
This lead CpG-site was related to the lead SNP (and to other SNPs in
that region), but since a further analysis showed that only 4% of the
total effect of the lead SNP on p,p′-DDE levels was mediated by the
lead methylation site, this effect seems to be of minor importance.
If an association between p,p′-DDE levels and a methylation site
within or close to a gene is seen, as in the present study, two possible ex-
planations exit. First, an SNPwithin or close to the gene governs the de-
gree of methylation at that particular site and this SNP is also related to
p,p′-DDE levels. In that case, the degree of methylation is a mediator of
the effect of the SNP on p,p′-DDE levels. This can be tested by SEM anal-
ysis as performed in the present study.
Second, themethylation site is not related to the SNPs in that region,
and therefore the effect of the methylation site on p,p′-DDE levels is in-
dependent of SNPs. In thepresent case, the leadmethylation sitewas re-
lated to several SNPs in the region, including the lead SNP, and therefore
the performed SEM analysis could conclude that the degree of methyl-
ation was of minor importance as compared to the effect of the SNP.
In the present study, it was disclosed that the association between
the p,p′-DDE levels and the lead methylation site was in fact governed
by a SNP. This ﬁnding is intriguing but it needs replication and corrobo-
ration by other studies in which genetic and epigenetic data are
available.
Just as in our previous study on genetic variation and PCB levels (Ng
et al., 2015b), we now found that the lead SNP is intronic. How intronic
variation inﬂuence protein levels and function is not fully understoodbut several mechanisms are likely to exist. First, an intronic variant
might be in linkage with a function SNP not measured or imputed. Sec-
ond, genetic and epigenetic variants in introns can inﬂuence expression
of different gene isoforms or alternative splicing. Third, alternative pro-
moters for transcription of gene variants could be inﬂuenced by intronic
variation.
The major strength of the present study is the large sample with
both p,p′-DDE measurements, and extensive genotyping and methyla-
tion data. The limitations include that our study is conducted in elderly
Caucasians, which limits the generalizability to other age- and ethnic
groups, and the fact thatwe cannot replicate ourﬁndings in an indepen-
dent sample, since we are not aware of other samples with both p,p′-
DDE measurements and genetic information.
A power analysis taken place before this study was conducted
showed that with approximately 1000 individuals in the study, we
have a limited power to detect relationshipswhere an exposurewill ex-
plain b4% of the outcome. Thus, it is not excluded that less powerful as-
sociations between p,p′-DDE and variation in other genes than CYP2B6
do exist.
The PIVUS study had a moderate participation rate of 50%. We have
made an analysis of the non-participants and found a slightly higher
prevalence of disabling disorders, such as stroke, but the prevalence's
of many other diseases, like hypertension and myocardial infarction
were similar in participants and non-participants (for details, see Lind
et al., 2005). It is a well-known experience in population-based epide-
miology that non-participants are somewhatmore sick the participants.
Since the aim of the present studywas to investigate links between p,p′-
DDE levels and genetics it will not be a disadvantage with a healthier
sample than the underlying population, since diseases tend to obscure
basic mechanisms of toxicokinetics.
It should also be acknowledged that a cross-sectional study has lim-
itations regarding mediation analysis. Here we postulated that genetic
variation- Nmethylation changes- N altered p,p′-DDE levels. Given the
cross sectional nature other alternative pathways might exists, like p,p′-
DDE- N altered methylation. Only longitudinal studies could solve those
issues. Another limitation is that the results from the whole genome
methylation assay were not validated by another type of assay.
In conclusion, genetic variation in the CYP2B6 gene was related to
circulating p,p′-DDE levels in the general elderly population. DNAmeth-
ylation in this gene does not seem to play amajor importance for the p,p
′-DDE levels, but the fact that both an untargeted genome-wide geno-
mic study and a methylation study linked p,p′-DDE levels to the
CYP2B6make it likely that CYP2B6 plays amajor role in themetabolism
of DDT in humans.Acknowledgements
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